Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18.
Several solute carriers and ATP-binding cassette transporters have been implicated in the influx or efflux of platinum-based chemotherapeutic agents such as cisplatin, carboplatin, and oxaliplatin. Given that many of these proteins are highly polymorphic, the genetic status of these proteins could be an important contributor to the extensive interindividual pharmacokinetic variability associated with the clinical use of these agents. In this review article, we provide an updated overview of the various transporters that have shown promise in animal models or patient populations in facilitating the movement of platinum-based agents across cell membranes, and how their function is associated with drug disposition or pharmacodynamic effects.
几种溶质载体和 ATP 结合盒转运蛋白已被牵涉到铂类化疗药物(如顺铂、卡铂和奥沙利铂)的流入或流出中。鉴于这些蛋白质中的许多都是高度多态的,这些蛋白质的遗传状态可能是与这些药物临床应用相关的广泛个体间药代动力学变异性的重要因素。在这篇综述文章中,我们提供了一个更新的概述,介绍了在动物模型或患者群体中表现出有希望促进铂类药物穿过细胞膜运动的各种转运蛋白,以及它们的功能如何与药物处置或药效学效应相关联。